Password reminder
No account yet? Register Free
About Us Advertising Info Contact Us Client Login
biotechdaily.com
Therapeutics
Features Subscription Partner Sites Journal Info
PZ HTL SAGLOBETECH PUBLISHING

New Method Devised for Treating Autoimmune Disease

By BiotechDaily International staff writers
Posted on 14 Jun 2012


Australian researchers have devised a new method that may regulate the body’s natural immune response, providing hope of a straightforward and effective treatment for autoimmune diseases.

The new approach involves increasing good regulating cells in the body, dissimilar to most current research which focuses on stopping “bad” (effector) cells, according to lead researcher Dr. Suzanne Hodgkinson, from University of New South Wales’ (UNSW) Faculty of Medicine (Sydney, Australia) and Liverpool Hospital.

The researchers triggered the body’s T-cell front-line defenses by injecting cell-signaling proteins called cytokines, in particular, cytokine interleukin-5 (II-5 cytokine). When T-regulatory cells are cultured in a way to make them specific to a particular protein, they develop receptors for the Il-5 cytokine. The Il-5 cytokine boost allows the body’s immune system to better regulate its response to disease without going into overdrive.

The team cloned II-5 cytokine and injected it into rats with the neurological condition Guillain-Barré syndrome. These rats recovered much faster, and if treated as a preventative, did not fall ill. The method has also shown potential in animals with multiple sclerosis, with kidney disease nephritis and trying to overcome organ transplantation rejection. “One of the nice things about this discovery is that it is one of the few treatments in the autoimmune world and in the transplantation world that works not by attacking the effector cells, but by increasing the good regulating cells. So it works in a very different way from almost every other treatment we've got available,” Dr. Hodgkinson said.

Il-5 injections could be more appetizing than inoculation by parasitic worms--another approach in regulating autoimmune disorders, according to the scientists. International research revealed that swallowing helminths parasites could regulate the immune system and increase T-cell production to fight disorders such as celiac disease and multiple sclerosis. The lack of the worms in guts in the developed world has been cited as a possible cause for the severe rise in autoimmune diseases in Western countries.

“The process we’ve developed may be the same process that the helminths kick off. When you get a helminths infestation, one of the changes in your immune response is an increase in cells called eosinophils and these cells make the cytokine interleukin-5,’ remarked Dr. Hodgkinson. “In this new treatment, it’s a matter of injecting the interleukin-5 and the body does the rest. It’s both safe and effective and we think inducing the immune response by injection may be more attractive to people than swallowing parasitic worms.”

The next phase of the research is to take the treatment to human trials, which could be undertaken within two to five years, Dr. Hodgkinson reported, whose study’s findings have has been published June 3, 2012, in the journal Blood.

Related Links:
University of New South Wales





PCR Workstation
PCR Workstation
Standard Probes
Standard Probes
Pipette
Pipette

More Products

Latest Therapeutics News

LinkXpress
Click for LinkXpress
Reader Inquiry Service
Enter code to receive information:
Where I can find code?
Featured Whitepaper
Veolia WATER:
Why pure water is important in modern chromatography

Download Whitepaper
Featured Video
BioTek:

View Video
Events
The 23rd Annual Scientific Meeting
09 Jul 2013 - 10 Jul 2013


27th Annual Symposium of the Protein Society
20 Jul 2013 - 24 Jul 2013


AACC 2013 – Annual Meeting of the American Association for Clinical Chemistry
28 Jul 2013 - 01 Aug 2013


More events
Latest Issue

View Digital Edition
Subscribe / Renew
GLOBETECH PUBLISHING'
PZ HTL SA
VISION-SCIENCES, INC.
  biotechdaily.com Copyright © 2000-2013 Globetech Media. All rights reserved.
Privacy Policy